- Home
- ELDN vs TSI Comparison
ELDN vs TSI Comparison
Compare ELDN & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- TSI
- Stock Information
- Founded
- ELDN 2004
- TSI 1987
- Country
- ELDN United States
- TSI United States
- Employees
- ELDN N/A
- TSI N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- TSI Investment Managers
- Sector
- ELDN Health Care
- TSI Finance
- Exchange
- ELDN Nasdaq
- TSI Nasdaq
- Market Cap
- ELDN 178.4M
- TSI 231.3M
- IPO Year
- ELDN N/A
- TSI N/A
- Fundamental
- Price
- ELDN $3.17
- TSI $4.93
- Analyst Decision
- ELDN Strong Buy
- TSI
- Analyst Count
- ELDN 1
- TSI 0
- Target Price
- ELDN $16.00
- TSI N/A
- AVG Volume (30 Days)
- ELDN 150.4K
- TSI 106.8K
- Earning Date
- ELDN 05-20-2025
- TSI 01-01-0001
- Dividend Yield
- ELDN N/A
- TSI 7.46%
- EPS Growth
- ELDN N/A
- TSI N/A
- EPS
- ELDN N/A
- TSI N/A
- Revenue
- ELDN N/A
- TSI N/A
- Revenue This Year
- ELDN N/A
- TSI N/A
- Revenue Next Year
- ELDN N/A
- TSI N/A
- P/E Ratio
- ELDN N/A
- TSI N/A
- Revenue Growth
- ELDN N/A
- TSI N/A
- 52 Week Low
- ELDN $2.00
- TSI $4.48
- 52 Week High
- ELDN $5.54
- TSI $4.87
- Technical
- Relative Strength Index (RSI)
- ELDN 48.82
- TSI 60.33
- Support Level
- ELDN $2.85
- TSI $4.85
- Resistance Level
- ELDN $3.51
- TSI $4.92
- Average True Range (ATR)
- ELDN 0.25
- TSI 0.04
- MACD
- ELDN 0.01
- TSI 0.01
- Stochastic Oscillator
- ELDN 45.07
- TSI 96.67
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.